Transcriptional Scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the Class II Major histocompatibility complex promoter

Molecular and Cellular Biology

Volumn 20, Issue 16, 2000, Pages 6051-6061

  Zhu, X S ^a   Linhoff, M W ^a   Li, G ^a   Chin, K C ^a   Maity, S N ^a   Ting, J P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; GENE CONTROL; GENE DELETION; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STEREOSPECIFICITY;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; COS CELLS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA-BINDING PROTEINS; GENES, MHC CLASS II; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0033861006     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.16.6051-6061.2000     Document Type: Article

References (58)

1. A variety of DNA-binding and multimeric proteins contain the histone fold motif
2. Regulation of major histocompatibility complex class-II genes: X, Y, and other letters of the alphabet
3. Analysis of the defect in IFN-γ induction of MHC class II genes in G1B cells: Identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X5 transcription factor
4. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
5. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction
6. Importance of acidic, proline/ serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: Generation of transdominant-negative mutants
7. Activation and transdominant suppression of MHC class II and HLA-DMB promoters by a series of C-terminal CIITA deletion mutants
8. The transcriptional activity of the CCAAT-binding factor CBF is mediated by two distinct activation domains, one in the CBF-B subunit and the other in the CBF-C subunit
9. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome
10. NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF
11. A cytoplasmic inhibitor of the JNK signal transduction pathway
12. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
13. The B subunit of the CAAT-binding factor NFY binds the central segment of the coactivator p300
14. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes
15. Conservation of the promoter region of DRA-like genes from nonhuman primates
16. MAP kinase pathways in the yeast Saccharomyces cerevisiae
17. GTP binding by class II transactivator: Role in nuclear import
18. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain
19. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y
20. In vivo footprinting of MHC class II genes: Bare promoter in the bare lymphocyte syndrome
21. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator
22. The proliferation of MAP kinase signaling pathways in yeast
23. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo
24. CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: The invariant chain promoter as a model
25. The B subunit of a rat heteromeric CCAAT-binding transcription factor shows a striking sequence identity with the yeast Hap2 transcription factor
26. Three different polypeptides are necessary for DNA binding of mammalian heteromeric CCAAT binding factor
27. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription
28. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients
29. CREB regulates MHC class II expression in a CIITA-dependent manner
30. Usage of primary cells to delineate IFN-gamma-responsive DNA elements in the HLA-DRA promoter and to identify a novel IFN-gamma-enhanced nuclear factor
31. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency
32. Class II transactivator and class II MHC gene expression in microglia: Modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10
33. Signal transduction by MAP kinase cascades in budding yeast
34. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y
35. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters
36. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: Similarities and distinctions with respect to HLA-DR-constitutive B cells
37. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)
38. Specific complex formation between the type II bare lymphocyte syndrome-associated trans-activators CIITA and RFX5
39. Analysis of protein phosphorylation
40. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3
41. Analysis of protein
42. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
43. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
44. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)
45. Major histocompatibility complex class II deficiency: A disease of gene regulation
46. Class II MHC genes: A model gene regulatory system with great biologic consequences
47. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function
48. Structural constraints within a trimeric transcriptional regulatory region: Constitutive and interferongamma inducible expression of the HLA-DRA gene
49. Purification and molecular cloning of the 'A' chain of a rat heteromeric CCAAT-binding protein. Sequence identity with the yeast HAP3 transcription factor
50. Structural organization of MAP-kinase signaling modules by scaffold
51. Mitogenactivated protein kinase: Conservation of a three-kinase module
52. In vivo footprint analysis of the HLADRA gene promoter: Cell-specific interaction at the octamer site and up regulation of X box binding by interferon gamma
53. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors
54. CIITA stimulation of transcription factor binding to MHC class II and associated promoters in vivo
55. The JIP group of mitogen-activated protein kinase scaffold proteins
56. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene
57. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency